Market Overview:
The global melanoma cancer market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of melanoma, rising awareness about skin cancer, and technological advancements in the field of diagnosis and treatment of melanoma. Based on type, the global melanoma cancer market is segmented into non-invasive melanoma and invasive melanoma. Non-invasive melanomas are further classified into superficial spreading malignant tumor (SSM), nodular malignant tumor (NM), lentigo maligna (LM), acral lentiginous malignant tumor (ALM) and other non-invasive tumors. Cutaneous T cell lymphomas are subclassified into mycosis fungoides, Sezary syndrome, primary cutaneous anaplastic large cell lymphoma(PCALCL), extranodal marginal zone B-cell lymphoproliferative disorder(EMZBLPD)and others . Mucosal Lentiginous Melanomas are subclassified into oral cavity cancers, esophageal cancers , anal canal cancers , vulvar cancers , penile cancers . Based on application, the global melonama cancer market is segmentedinto hospitalsandcancer research centers.
Product Definition:
Melanoma cancer is a type of cancer that begins in the melanocytes, which are the cells that produce melanin. Melanin is the pigment that gives skin its color. Melanoma cancers can occur on any part of the body, but they are most common on the arms, legs, trunk, and head and neck areas.
Non-invasive melanoma:
Non-invasive melanoma is a type of skin cancer that develops in the pigment-producing cells of the skin. These cells are found in many areas of the body, but they are most commonly located on or near the neck, back, and legs.
Invasive melanoma:
Invasive melanoma is the most serious type of skin cancer. It has a high rate of occurrence, especially in people with dark skin. The American Academy of Dermatology (AAD) estimates that 1 in every 4 women and 1 in every 5 men are likely to develop invasive melanoma in their lifetime. As per the AAD statistics, around 9,100 people were diagnosed with melanoma and 2,300 deaths were reported due to it in U.S.
Application Insights:
The oncology segment dominated the market in 2017 and is expected to witness a CAGR of XX% over the forecast period owing to an increase in cancer cases due to unmet medical needs and rising awareness about early diagnosis. Increasing prevalence of sun-related diseases, such as melanoma, across all age groups coupled with increasing spending power of consumers are some factors that may drive this application segment over the forecast period.
The hospitals segment held a revenue share of 28.1% in 2017 owing to an increase in hospital-based research activities for discovering new treatment options for metastatic disease stages along with high government funding for clinical trials at hospitals and cancer centers worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of technologically advanced products, high patient awareness levels coupled with a strong healthcare system. The region is expected to maintain its dominance throughout the forecast period owing to increasing R&D investments by companies and an increase in drug approvals. Asia Pacific is estimated to witness lucrative growth over the forecast period due to rising disposable income levels, improving economic conditions and growing health awareness among people leading themselve sto demand for treatment options other than surgery or chemo-otherapy.
Growth Factors:
- Increasing incidence of melanoma cancer
- Growing awareness about melanoma cancer and its symptoms
- Rising demand for better treatment options for melanoma cancer
- increasing number of research and development activities for the treatment of melanoma cancer
- growing number of collaborations between pharmaceutical companies and research institutes to develop new drugs for the treatment of melanoma
Scope Of The Report
Report Attributes
Report Details
Report Title
Melanoma Cancer Market Research Report
By Type
Non-invasive melanoma, Invasive melanoma
By Application
Hospitals, Cancer Research Centers
By Companies
AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Melanoma Cancer Market Report Segments:
The global Melanoma Cancer market is segmented on the basis of:
Types
Non-invasive melanoma, Invasive melanoma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Cancer Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AB Sciences
- Incyte
- Merck
- Novartis
- Pierre Fabre
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Daiichi Sankyo
Highlights of The Melanoma Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-invasive melanoma
- Invasive melanoma
- By Application:
- Hospitals
- Cancer Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melanoma Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Melanoma cancer is a type of skin cancer that can occur anywhere on the body. It's the most serious form of skin cancer, and it can be deadly if not treated quickly. Melanoma cells are more likely to spread to other parts of the body than other types of skin cancers, and they're also more likely to grow back after being treated.
Some of the major companies in the melanoma cancer market are AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo.
The melanoma cancer market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melanoma Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melanoma Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melanoma Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melanoma Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melanoma Cancer Market Size & Forecast, 2020-2028
4.5.1 Melanoma Cancer Market Size and Y-o-Y Growth
4.5.2 Melanoma Cancer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Non-invasive melanoma
5.2.2 Invasive melanoma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Cancer Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melanoma Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melanoma Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Non-invasive melanoma
9.6.2 Invasive melanoma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Cancer Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Non-invasive melanoma
10.6.2 Invasive melanoma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Cancer Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Non-invasive melanoma
11.6.2 Invasive melanoma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Cancer Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Non-invasive melanoma
12.6.2 Invasive melanoma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Cancer Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Non-invasive melanoma
13.6.2 Invasive melanoma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Cancer Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melanoma Cancer Market: Competitive Dashboard
14.2 Global Melanoma Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AB Sciences
14.3.2 Incyte
14.3.3 Merck
14.3.4 Novartis
14.3.5 Pierre Fabre
14.3.6 Amgen
14.3.7 AstraZeneca
14.3.8 Bristol-Myers Squibb
14.3.9 Daiichi Sankyo
